Please ensure Javascript is enabled for purposes of website accessibility
홈 > 제품 > 재조합 단백질 > 면역 체크포인트 단백질

Human Siglec-2/CD22 Recombinant Protein (C-His) (HB011021)

Human Siglec-2/CD22 Recombinant Protein (C-His)
Human Siglec-2/CD22 Recombinant Protein (C-His)
Human Siglec-2/CD22 Recombinant Protein (C-His)
Human Siglec-2/CD22 Recombinant Protein (C-His)
Human Siglec-2/CD22 Recombinant Protein (C-His)
Human Siglec-2/CD22 Recombinant Protein (C-His)
Human Siglec-2/CD22 Recombinant Protein (C-His)
Human Siglec-2/CD22 Recombinant Protein (C-His)
Human Siglec-2/CD22 Recombinant Protein (C-His)
Human Siglec-2/CD22 Recombinant Protein (C-His)
Human Siglec-2/CD22 Recombinant Protein (C-His)
Human Siglec-2/CD22 Recombinant Protein (C-His)
가격(USD):
사양:
  • 50ug
  • 100ug
  • 1mg
수량:
문의하기
  • 개요

  • 이미지

  • 참고 문헌

  • 데이터시트

  • SDS

개요
카탈로그 번호HB011021
설명
Recombinant Human CD22 Protein, C-His (HB011021) expressed in Mammalian Cells, spanning Met1-Arg687. Purity: >90% by SDS-PAGE.
Highlights
  • ●His-Tagged — N-terminal 6×His tag for IMAC purification.
  • ●Mammalian Expression — Proper folding and native glycosylation.
  • ●High Purity — >90% purity verified by SDS-PAGE.
발현 시스템Mammalian cells
등록번호P20273
단백질 길이Met1-Arg687
응용 분야ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
종Homo sapiens (Human)
성질 Recombinant
테스트된 응용 분야 WB
타겟 B-cell receptor CD22, B-lymphocyte cell adhesion molecule, BL-CAM, CD22, SIGLEC2, Sialic acid-binding Ig-like lectin 2, Siglec-2, T-cell surface antigen Leu-14
내독소 수준 Please contact with the lab for this information.
순도 >90% as determined by SDS-PAGE.
예측 분자량 78.32 kDa
형태 Lyophilized
저장 완충액 Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.

데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요.

재구성 Reconstitute in sterile water for a stock solution. Adjust the volume of sterile water so that, after reconstitution, the final stock concentration matches the value indicated on the product label or datasheet.

RECONSTITUTION PROTOCOL
1. Allow the product to be reconstituted and the reconstitution diluent to reach room temperature.
2. Tap or briefly centrifuge the product vial before opening to dislodge any lyophilized material that may be dispersed on the wall or cap of the vial.
3. Use the diluent and stock concentration recommended in the product datasheet. If preparing a stock concentration higher than recommended, contact Technical Service.
4. After adding the diluent, re-cap the vial and invert gently by hand or place on a slow rocking platform to allow the reconstitution diluent to coat all the surfaces inside the vial. Note: Do not mix by vortexing or by pipetting the material up and down.
5. Allow the vial to sit at room temperature with gentle agitation for at least 15 minutes before aliquotting or using.
6. Store the reconstituted material in single use aliquots in polypropylene or siliconized tubes. Aliquots of 10 μL or larger are recommended.
배송 In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
안정성 및 저장 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
대체 이름B-cell receptor CD22, B-lymphocyte cell adhesion molecule, BL-CAM, CD22, SIGLEC2, Sialic acid-binding Ig-like lectin 2, Siglec-2, T-cell surface antigen Leu-14
배경

B-cell receptor CD22 is a ~95 kDa protein. Most highly expressed siglec (sialic acid-binding immunoglobulin-like lectin) on B-cells that plays a role in various aspects of B-cell biology including differentiation, antigen presentation, and trafficking to bone marrow. Binds to alpha 2,6-linked sialic acid residues of surface molecules such as CD22 itself, CD45 and IgM in a cis configuration. Can also bind to ligands on other cells as an adhesion molecule in a trans configuration. Acts as an inhibitory coreceptor on the surface of B-cells and inhibits B-cell receptor induced signaling, characterized by inhibition of the calcium mobilization and cellular activation. Mechanistically, the immunoreceptor tyrosine-based inhibitory motif domain is phosphorylated by the Src kinase LYN, which in turn leads to the recruitment of the protein tyrosine phosphatase 1/PTPN6, leading to the negative regulation of BCR signaling. CD22 is the therapeutic target of inotuzumab ozogamicin (Besponsa).

1. Meyer, SJ. et al. (2021) Journal of immunology (Baltimore, Md. : 1950) 207, 1018-1032. PMID: 34330755
2. Law, CL. et al. (1996) The Journal of experimental medicine 183, 547-60. PMID: 8627166
3. Ramya, TN. et al. (2010) Molecular & cellular proteomics : MCP 9, 1339-51. PMID: 20172905
4. Séïté, JF. et al. (2010) Blood 116, 1698-704. PMID: 20516366
참고사항 For research use only.
이미지
  • Human Siglec-2/CD22 Recombinant Protein (C-His)

    SDS-PAGE

    SDS-PAGE for Recombinant Human CD22 Protein, C-His

  • Human Siglec-2/CD22 Recombinant Protein (C-His)

    Bioactivity

    Detects Immurait-Ll2Mab in indirect ELISAs.

  • Human Siglec-2/CD22 Recombinant Protein (C-His)

    Bioactivity

    Detected by Research Grade Anti-Human CD22 (M972) in indirect ELISA.

  • Human Siglec-2/CD22 Recombinant Protein (C-His)

    Bioactivity

    Detected by Research Grade Rezetamig (Cat No.: HB011196) in indirect ELISA.

  • Human Siglec-2/CD22 Recombinant Protein (C-His)

    Western blot

    Detected by Anti-CD22 monoclonal antibody (Catalog No: HB011196)

  • Human Siglec-2/CD22 Recombinant Protein (C-His)

    Bioactivity

    Detected by Suciraslimab (Catalog No: HB011096) in indirect ELISA.

참고 문헌
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
추천

문의하기 맞춤형 견적, 대량 주문 및 기타 문의 사항은

메일: [email protected]

배급사 목록